Schedule 13G ownership disclosure

ELEDON PHARMACEUTICALS INC COM

Security class unavailable · CUSIP: 28617K101

Event date: 2022-01-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-22-000117
Form type
SC 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Jan 11, 2022
Reporting period
Jan 06, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub